These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18544291)

  • 1. Measurement of utility in nonmelanoma skin cancer.
    Lear W; Akeroyd JE; Mittmann N; Murray C
    J Cutan Med Surg; 2008; 12(3):102-6. PubMed ID: 18544291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
    Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
    J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
    Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
    J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
    Seleit I; Bakry OA; Samaka RM; Malak MA
    Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creation of a quality of life instrument for nonmelanoma skin cancer patients.
    Rhee JS; Matthews BA; Neuburg M; Burzynski M; Nattinger AB
    Laryngoscope; 2005 Jul; 115(7):1178-85. PubMed ID: 15995503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effect of surgical treatment on quality of life with the Dermatology Life Quality Index in patients with facial nonmelanoma skin cancer.
    Çetinarslan T; Evrenos MK; Bilaç C; Özyurt B; Türel Ermertcan A
    Dermatol Ther; 2020 Nov; 33(6):e14094. PubMed ID: 32725850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in non-melanoma skin cancer.
    Gaulin C; Sebaratnam DF; Fernández-Peñas P
    Australas J Dermatol; 2015 Feb; 56(1):70-6. PubMed ID: 25196191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS
    J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chen T; Bertenthal D; Sahay A; Sen S; Chren MM
    Arch Dermatol; 2007 Nov; 143(11):1386-92. PubMed ID: 18025362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life issues in nonmetastatic skin cancer.
    Burdon-Jones D; Thomas P; Baker R
    Br J Dermatol; 2010 Jan; 162(1):147-51. PubMed ID: 19796177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient utilities in fibromyalgia and the association with other outcome measures.
    Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1995 Aug; 22(8):1536-43. PubMed ID: 7473480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
    Healy E; Collins P; Barnes L
    Ir Med J; 1995; 88(2):58-9. PubMed ID: 7775148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index.
    Rhee JS; Matthews BA; Neuburg M; Smith TL; Burzynski M; Nattinger AB
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):525-9. PubMed ID: 15056143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
    Zaravinos A; Kanellou P; Spandidos DA
    Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients.
    Kassem A; Technau K; Kurz AK; Pantulu D; Löning M; Kayser G; Stickeler E; Weyers W; Diaz C; Werner M; Nashan D; Zur Hausen A
    Int J Cancer; 2009 Jul; 125(2):356-61. PubMed ID: 19384948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility score.
    Grunberg SM; Srivastava A; Grunberg KJ; Weeks J
    Support Care Cancer; 2002 Nov; 10(8):624-9. PubMed ID: 12436221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological study of perilesional skin in patients diagnosed with nonmelanoma skin cancer.
    Apalla Z; Calzavara-Pinton P; Lallas A; Argenziano G; Kyrgidis A; Crotti S; Facchetti F; Monari P; Gualdi G
    Clin Exp Dermatol; 2016 Jan; 41(1):21-5. PubMed ID: 26189480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.